Announcements Trials
Browse Landscape

Status

Completed 4Terminated 2No longer available 1

Sponsor Class

NETWORK 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 1

Interventions

TIC10 compound 23-Iodobenzylguanidine 2tucatinib 1rindopepimut 1pembrolizumab 1pegfilgrastim 1paclitaxel-Angiopep-2 conjugate 1omburtamab I-131 1mogamulizumab 1gallium maltolate 1fluorodopa F 18 1efineptakin alfa 1avapritinib 1Vorinostat 1Potassium Iodide 1OKN 007 1Ketoconazole 1Ipilimumab 1Granulocyte Colony-Stimulating Factor 1Fenretinide 1Cancer Vaccines 1Adjuvants, Immunologic 1ABT-414 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Fenretinide × CNS × Clear all
NCT02075177 2022-03-21

Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma

South Plains Oncology Consortium

No longer available
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡